BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 34876467)

  • 1. GCH1 Deficiency Activates Brain Innate Immune Response and Impairs Tyrosine Hydroxylase Homeostasis.
    Larbalestier H; Keatinge M; Watson L; White E; Gowda S; Wei W; Koler K; Semenova SA; Elkin AM; Rimmer N; Sweeney ST; Mazzolini J; Sieger D; Hide W; McDearmid J; Panula P; MacDonald RB; Bandmann O
    J Neurosci; 2022 Jan; 42(4):702-716. PubMed ID: 34876467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catecholamines and Parkinson's disease: tyrosine hydroxylase (TH) over tetrahydrobiopterin (BH4) and GTP cyclohydrolase I (GCH1) to cytokines, neuromelanin, and gene therapy: a historical overview.
    Nagatsu T
    J Neural Transm (Vienna); 2023 Aug; ():. PubMed ID: 37638996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human tyrosine hydroxylase in Parkinson's disease and in related disorders.
    Nagatsu T; Nakashima A; Ichinose H; Kobayashi K
    J Neural Transm (Vienna); 2019 Apr; 126(4):397-409. PubMed ID: 29995172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low frequency of GCH1 and TH mutations in Parkinson's disease.
    Rengmark A; Pihlstrøm L; Linder J; Forsgren L; Toft M
    Parkinsonism Relat Disord; 2016 Aug; 29():109-11. PubMed ID: 27185167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics of dopa-responsive dystonia.
    Ichinose H; Suzuki T; Inagaki H; Ohye T; Nagatsu T
    Biol Chem; 1999 Dec; 380(12):1355-64. PubMed ID: 10661862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects.
    Nagatsu T; Nagatsu I
    J Neural Transm (Vienna); 2016 Nov; 123(11):1255-1278. PubMed ID: 27491309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dopa-responsive dystonia: clinical, genetic, and biochemical studies].
    Furukawa Y
    Rinsho Shinkeigaku; 2006 Jan; 46(1):19-34. PubMed ID: 16541791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of GCH1 and TH genes in Chinese patients with Parkinson's disease.
    Yan YP; Zhang B; Shen T; Si XL; Guo ZY; Tian J; Xu CY; Zhang BR
    Neurobiol Aging; 2018 Aug; 68():159.e3-159.e6. PubMed ID: 29724574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GTP cyclohydrolase I and tyrosine hydroxylase gene mutations in familial and sporadic dopa-responsive dystonia patients.
    Cai C; Shi W; Zeng Z; Zhang M; Ling C; Chen L; Cai C; Zhang B; Li WD
    PLoS One; 2013; 8(6):e65215. PubMed ID: 23762320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.
    Mencacci NE; Isaias IU; Reich MM; Ganos C; Plagnol V; Polke JM; Bras J; Hersheson J; Stamelou M; Pittman AM; Noyce AJ; Mok KY; Opladen T; Kunstmann E; Hodecker S; Münchau A; Volkmann J; Samnick S; Sidle K; Nanji T; Sweeney MG; Houlden H; Batla A; Zecchinelli AL; Pezzoli G; Marotta G; Lees A; Alegria P; Krack P; Cormier-Dequaire F; Lesage S; Brice A; Heutink P; Gasser T; Lubbe SJ; Morris HR; Taba P; Koks S; Majounie E; Raphael Gibbs J; Singleton A; Hardy J; Klebe S; Bhatia KP; Wood NW;
    Brain; 2014 Sep; 137(Pt 9):2480-92. PubMed ID: 24993959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GTP cyclohydrolase I gene, tetrahydrobiopterin, and tyrosine hydroxylase gene: their relations to dystonia and parkinsonism.
    Nagatsu T; Ichinose H
    Neurochem Res; 1996 Feb; 21(2):245-50. PubMed ID: 9182249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GCH1 mutations in dopa-responsive dystonia and Parkinson's disease.
    Yoshino H; Nishioka K; Li Y; Oji Y; Oyama G; Hatano T; Machida Y; Shimo Y; Hayashida A; Ikeda A; Mogushi K; Shibagaki Y; Hosaka A; Iwanaga H; Fujitake J; Ohi T; Miyazaki D; Sekijima Y; Oki M; Kusaka H; Fujimoto KI; Ugawa Y; Funayama M; Hattori N
    J Neurol; 2018 Aug; 265(8):1860-1870. PubMed ID: 29948246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopa-responsive dystonia in Chinese patients: Including a novel heterozygous mutation in the GCH1 gene with an intermediate phenotype and one case of prenatal diagnosis.
    Zhang W; Zhou Z; Li X; Huang Y; Li T; Lin Y; Shao Y; Hu H; Liu H; Liu L
    Neurosci Lett; 2017 Mar; 644():48-54. PubMed ID: 28087438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common and rare GCH1 variants are associated with Parkinson's disease.
    Rudakou U; Ouled Amar Bencheikh B; Ruskey JA; Krohn L; Laurent SB; Spiegelman D; Liong C; Fahn S; Waters C; Monchi O; Fon EA; Dauvilliers Y; Alcalay RN; Dupré N; Gan-Or Z
    Neurobiol Aging; 2019 Jan; 73():231.e1-231.e6. PubMed ID: 30314816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetics of hereditary dystonia--mutations in the GTP cyclohydrolase I gene.
    Ichinose H; Nagatsu T
    Brain Res Bull; 1997; 43(1):35-8. PubMed ID: 9205791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GTP cyclohydrolase I gene, dystonia, juvenile parkinsonism, and Parkinson's disease.
    Nagatsu T; Ichinose H
    J Neural Transm Suppl; 1997; 49():203-9. PubMed ID: 9266429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia.
    Furukawa Y; Nygaard TG; Gütlich M; Rajput AH; Pifl C; DiStefano L; Chang LJ; Price K; Shimadzu M; Hornykiewicz O; Haycock JW; Kish SJ
    Neurology; 1999 Sep; 53(5):1032-41. PubMed ID: 10496263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemistry of postmortem brains in Parkinson's disease: historical overview and future prospects.
    Nagatsu T; Sawada M
    J Neural Transm Suppl; 2007; (72):113-20. PubMed ID: 17982884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low frequency of Parkin, Tyrosine Hydroxylase, and GTP Cyclohydrolase I gene mutations in a Danish population of early-onset Parkinson's Disease.
    Hertz JM; Ostergaard K; Juncker I; Pedersen S; Romstad A; Møller LB; Güttler F; Dupont E
    Eur J Neurol; 2006 Apr; 13(4):385-90. PubMed ID: 16643317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms underlying the efficacy and limitation of dopa and tetrahydrobiopterin therapies for the deficiency of GTP cyclohydrolase 1 revealed in a novel mouse model.
    Jiang X; Shao Y; Liao Y; Zheng X; Peng M; Cai Y; Wang M; Liu H; Zeng C; Lin Y; Zhang W; Liu L
    Eur J Pharmacol; 2024 Mar; 967():176379. PubMed ID: 38342361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.